Datametrex AI Limited (DM)
4.960
+0.050 (1.02%)
Inactive · Last trade price on Apr 1, 2025

Company Description

Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea.

The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.

The company provides big data, artificial intelligence, and system integration services, as well as sells hardware equipment.

In addition, the company offers AnalyticsGPT, an AI and Machine Learning platform; cyber security nexology comprising NexaSecurity, a social media discovery and monitoring platform and NexaSMART; imagine health care centers, a multidisciplinary healthcare facility; Medi-call, a telehealth platform for iOS and Android devices, as well as mobile gaming, a cereal crunch app.

Further, it provides mobile charging services, EV charging stations, Mobile EV chargers, and AC EV chargers.

The company is headquartered in Toronto, Canada.

Datametrex AI Limited
Desktop Metal logo
Country Canada
Founded 2015
Industry Computer Hardware
Sector Technology
Employees 950
CEO Paul Haber

Contact Details

Address:
2300 Yonge Street
Toronto, Ontario M4P 1E4
Canada
Phone 978 224 1244
Website datametrex.com

Stock Details

Ticker Symbol DM
Exchange NYSE
Fiscal Year April - March
Reporting Currency CAD
CIK Code 0001603286
CUSIP Number 25058X105
ISIN Number US25058X1054
Employer ID 46-5135781
SIC Code 7374

Key Executives

Name Position
Ric Fulop Co-Founder, Chairman and Chief Executive Officer
Jonah Myerberg Co-Founder, Chief Technology Officer and Senior Vice President of Global Engineering
Thomas Nogueira Chief Operating Officer
Rick Chin Co-Founder
Dr. Emanuel M. Sachs Ph.D. Co-Founder
Prof. Christopher A. Schuh Ph.D. Co-Founder
Prof. A. John Hart Ph.D. Co-Founder
Dr. Yet-Ming Chiang Co-Founder
Larry O'Connell General Counsel and Secretary
Sarah Webster Chief Marketing Officer

Latest SEC Filings

Date Type Title
Feb 27, 2019 15-12B Securities registration termination
Feb 20, 2019 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Feb 12, 2019 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 4, 2019 EFFECT Notice of Effectiveness
Feb 1, 2019 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 30, 2019 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 29, 2019 8-K Current Report
Jan 28, 2019 POS AM Post-Effective amendments for registration statement
Jan 28, 2019 RW Filing
Jan 28, 2019 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments